Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A structured evaluation of cryopreservation in generating single-cell transcriptomes from cerebrospinal fluid.
Touil H, Roostaei T, Calini D, Diaconu C, Epstein S, Raposo C, Onomichi K, Thakur KT, Craveiro L, Callegari I, Bryois J, Riley CS, Menon V, Derfuss T, De Jager PL, Malhotra D. Touil H, et al. Among authors: derfuss t. Cell Rep Methods. 2023 Jul 14;3(7):100533. doi: 10.1016/j.crmeth.2023.100533. eCollection 2023 Jul 24. Cell Rep Methods. 2023. PMID: 37533636 Free PMC article.
Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
Filippidis P, Damas J, Viala B, Assal F, Nawej Tshikung O, Tarr P, Derfuss T, Oberholzer M, Jelcic I, Hundsberger T, Sacco L, Cavassini M, Du Pasquier R, Darling KEA; NAMACO study group, Swiss HIV Cohort Study. Filippidis P, et al. Among authors: derfuss t. J Acquir Immune Defic Syndr. 2023 Jul 1;93(3):219-228. doi: 10.1097/QAI.0000000000003189. J Acquir Immune Defic Syndr. 2023. PMID: 36927958 Free article.
De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.
Androdias G, Lünemann JD, Maillart E, Amato MP, Audoin B, Bruijstens AL, Bsteh G, Butzkueven H, Ciccarelli O, Cobo-Calvo A, Derfuss T, Di Pauli F, Edan G, Enzinger C, Geraldes R, Granziera C, Hacohen Y, Hartung HP, Hynes S, Inglese M, Kappos L, Kuusisto H, Langer-Gould A, Magyari M, Marignier R, Montalban X, Mycko MP, Nourbakhsh B, Oh J, Oreja-Guevara C, Piehl F, Prosperini L, Sastre-Garriga J, Sellebjerg F, Selmaj K, Siva A, Tallantyre E, van Pesch V, Vukusic S, Weinstock-Guttman B, Zipp F, Tintoré M, Iacobaeus E, Stankoff B. Androdias G, et al. Among authors: derfuss t. Brain. 2024 Dec 21:awae409. doi: 10.1093/brain/awae409. Online ahead of print. Brain. 2024. PMID: 39707906
Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated Disease.
Gomes ABAGR, Kim SH, Pretzsch R, Kulsvehagen L, Schaedelin S, Lerner J, Wetzel NS, Benkert P, Maleska Maceski A, Hyun JW, Lecourt AC, Lipps P, Schoeps VA, Matos AMB, Mendes NT, Apóstolos-Pereira SL, Mehling M, Derfuss T, Kappos L, Callegaro D, Kuhle J, Kim HJ, Pröbstel AK. Gomes ABAGR, et al. Among authors: derfuss t. Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200347. doi: 10.1212/NXI.0000000000200347. Epub 2024 Dec 20. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39705633 Free article.
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.
Benkert P, Maleska Maceski A, Schaedelin S, Oechtering J, Zadic A, Vilchez Gomez JF, Melie-Garcia L, Cagol A, Galbusera R, Subramaniam S, Lorscheider J, Galli E, Mueller J, Fischer-Barnicol B, Achtnichts L, Findling O, Lalive PH, Bridel C, Uginet M, Müller S, Pot C, Mathias A, Du Pasquier R, Salmen A, Hoepner R, Chan A, Disanto G, Zecca C, D'Souza M, Hemkens LG, Yaldizli Ö, Derfuss T, Roth P, Gobbi C, Brassat D, Tackenberg B, Pedotti R, Raposo C, Oksenberg J, Wiendl H, Berger K, Hermesdorf M, Piehl F, Conen D, Buser A, Kappos L, Khalil M, Granziera C, Abdelhak A, Leppert D, Willemse EAJ, Kuhle J; Swiss MS Cohort study (SMSC). Benkert P, et al. Among authors: derfuss t. Ann Neurol. 2024 Oct 16. doi: 10.1002/ana.27096. Online ahead of print. Ann Neurol. 2024. PMID: 39411917
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.
Derfuss T, Bermel R, Lin CJ, Hauser SL, Kappos L, Vollmer T, Comi G, Giovannoni G, Hartung HP, Weber MS, Wang J, Jessop N, Chognot C, Craveiro L, Bar-Or A. Derfuss T, et al. Ther Adv Neurol Disord. 2024 Oct 8;17:17562864241277736. doi: 10.1177/17562864241277736. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39399100 Free PMC article.
Case report: Concurrent MOG antibody-associated disease and latent infections in two patients.
Kulsvehagen L, Woelfle T, Ayroza Galvão Ribeiro Gomes AB, Lipps P, Neziraj T, Flammer J, Leuzinger K, Derfuss T, Kuhle J, Papadopoulou A, Pröbstel AK. Kulsvehagen L, et al. Among authors: derfuss t. Front Immunol. 2024 Sep 4;15:1455355. doi: 10.3389/fimmu.2024.1455355. eCollection 2024. Front Immunol. 2024. PMID: 39295869 Free PMC article.
MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial.
Janiaud P, Zecca C, Salmen A, Benkert P, Schädelin S, Orleth A, Demuth L, Maceski AM, Granziera C, Oechtering J, Leppert D, Derfuss T, Achtnichts L, Findling O, Roth P, Lalive P, Uginet M, Müller S, Pot C, Hoepner R, Disanto G, Gobbi C, Rooshenas L, Schwenkglenks M, Lambiris MJ, Kappos L, Kuhle J, Yaldizli Ö, Hemkens LG. Janiaud P, et al. Among authors: derfuss t. Trials. 2024 Sep 11;25(1):607. doi: 10.1186/s13063-024-08454-6. Trials. 2024. PMID: 39261900 Free PMC article.
Targeting cytokine networks in neuroinflammatory diseases.
Becher B, Derfuss T, Liblau R. Becher B, et al. Among authors: derfuss t. Nat Rev Drug Discov. 2024 Nov;23(11):862-879. doi: 10.1038/s41573-024-01026-y. Epub 2024 Sep 11. Nat Rev Drug Discov. 2024. PMID: 39261632 Review.
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort.
Greselin M, Lu PJ, Melie-Garcia L, Ocampo-Pineda M, Galbusera R, Cagol A, Weigel M, de Oliveira Siebenborn N, Ruberte E, Benkert P, Müller S, Finkener S, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb JM, Diepers M, Wagner F, Vargas MI, Pasquier RD, Lalive PH, Pravatà E, Weber J, Gobbi C, Leppert D, Kim OC, Cattin PC, Hoepner R, Roth P, Kappos L, Kuhle J, Granziera C. Greselin M, et al. Among authors: derfuss t. Bioengineering (Basel). 2024 Aug 22;11(8):858. doi: 10.3390/bioengineering11080858. Bioengineering (Basel). 2024. PMID: 39199815 Free PMC article.
197 results